The cost and mortality of hip fractures in centenarians

J Moore1,2, O Carmody3, B Carey3

  • 1Department of Trauma and Orthopaedics, Cork University Hospital, Cork, Ireland. jossymoore@hotmail.com.

Insights

Hip fractures in centenarians are costly but operative management is suggested. This study found a 71% 1-year mortality rate, comparable to the expected lifespan for this age group.

Area of Science:

  • Geriatric Medicine
  • Orthopedic Surgery
  • Health Economics

Background:

  • Centenarians represent a rapidly growing demographic in Ireland.
  • Hip fractures in the elderly are linked to high morbidity, mortality, and healthcare costs.
  • Limited data exists on hip fractures specifically in centenarians.

Purpose of the Study:

  • To examine the experience of hip fractures in centenarians.
  • To determine the treatment costs associated with these fractures.
  • To assess the social and economic impact on the healthcare system.

Main Methods:

  • Retrospective data review at a major trauma center (2010-2016).
  • Identified nine proximal femoral fractures in patients over 100 years old.
  • Calculated inpatient costs using length of stay, theatre time, and implant costs.

Main Results:

  • Nine centenarians underwent operative management for hip fractures.
  • Average inpatient cost was €14,898 per patient.
  • Inpatient, 30-day, and 1-year mortality rates were 22%, 22%, and 71%, respectively.

Conclusions:

  • The 1-year mortality rate (71%) is comparable to the expected mortality for individuals aged 100+.
  • Operative management should be considered for the extreme elderly with hip fractures.
  • This approach may mitigate some of the social and economic burdens.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.8K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
294
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
283
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
306
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
294
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
334